IBanga lobuChiza 1009119-65-6 iDaclatasvir yoNyango lweHepatitis C Umfanekiso ofakiweyo

IBanga le-Pharmaceutical 1009119-65-6 iDaclatasvir yoNyango lweHepatitis C

Inkcazelo emfutshane:

Ubunyulu:≧99.0%

ImiGangatho yoMgangatho:Njengoko kufuneka

Isatifikethi:I-COA, i-MOA, i-MSDS, njl.

Umthamo:50Kgs ngenyanga

Beka ubomi kwishelufa:Iminyaka emibini

Isicelo:i-inhibitor ye-nonstructural protein 5A kwaye isetyenziselwa unyango lwe-hepatitis C

Iqela eliluncedo:Iqela lokuthengisa impahla ngaphandle elinamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	Daclatasvir2HCl
Izithethantonye	N,N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1) -methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;BMS 790052
Inombolo yeCAS.	1009119-65-6
Imbonakalo	Umgubo omhlophe ukuya kumthubi
Ifomula yeemolekyuli	C₄₀H₅₀N₈O₆.2(HCl)
Ubunzima beMolekyuli	811.81
Ukusetyenziswa	IBanga lezoKhemesti ngenjongo yoPhando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

Daclatasvir2HCl Cas:1009119-65-6
Izinto	Umgangatho	Iziphumo
Iimpawu	Umgubo omhlophe ukuya kumthubi	Umgubo ophale-tyheli
Isiqulatho samanzi	≦1.0%	0.25%
Ubunyulu	≧99%	99.7%
Ukungcola okukodwa	≦0.1%	0.06%
Intsalela ekutshisweni	≦0.1%	Iyahambelana
Ukuqukumbela	Ihambelana neenkcukacha zangaphakathi.

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf